of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008), Paragraph 2 of Section 100, Section 114, Section 115, Section 116 and
with Section 33, Section 34, Section 36, Section 41, Section 43 and Section 45 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Securities and Exchange Commission acting as
with Section 33, Section 34, Section 36, Section 41, Section 43 and Section 45 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Securities and Exchange Commission acting as
with Section 33, Section 34, Section 36, Section 41, Section 43 and Section 45 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Securities and Exchange Commission acting as
Office of the Securities and Exchange Commission (SEC Office) In this Application, we Full name (in Thai) Full name (in English) Passport No. E-mail Address Mobile phone Status of the Applicant General
securities and exchange, the Exchange’s regulation, and the law relating to the Company’s business; (4) To consider, select and nominate an independent person to be the Company’s auditor, and to propose such
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
No. WPH-SET 9/2019 August 9, 2019 Subject : The expansion of Wattanapat Samui Hospital project To : Director and Manager The Stock Exchange of Thailand Enclosure: The Acquisition and Disposition of
No. WPH-SET 9/2019 August 9, 2019 Subject : The expansion of Wattanapat Samui Hospital project To : Director and Manager The Stock Exchange of Thailand Enclosure: The Acquisition and Disposition of
มี อนุพันธแฝง (Structured Note) ซ่ึงมีการจายผลตอบแทนอางอิงกับดัชนีอางอิง (Underlying) ไดแก ดัชนี iSTOXX® Global Transformation Select 30 NR Risk Control 10% Decrement 4% Index โดยมลูคา หรือจํานว